Indian drug maker Dr Reddy's Laboratories has confirmed that it has started marketing its anti-osteoporosis drug Ibandronate Sodium in the American market, which will be available in 150 mg dose tablet form.
The generic version of Roche's Boniva, Ibandronate Sodium is used in treating post-menopausal osteoporosis. Dr Reddy's abbreviated new drug application (ANDA) was approved by the US Food and Drug Administration after the company had been locked in a legal battle with Roche over a patent dispute since 2007.
Boniva had managed to clock up sales of more than $486 million in the US market last year, according to figures released by IMS Health. Confirming the launch of the drug Dr Reddy's Laboratories said, "The tablets are available in the cartons of three blister packs containing 1 tablet each."